Related Experiment Videos
[11th International Histocompatibility Workshop 1991: Personal data for the Multiple Sclerosis Study].
1Institut für Transfusionsmedizin Rostock, DRK-Blutspendedienst MV, BRD.
Beitrage Zur Infusionstherapie = Contributions to Infusion Therapy
|January 1, 1992
Summary
This study investigated multiple sclerosis (MS) genetic factors, finding a strong association with HLA-DRw15 and -DWw6. Complement factors like C2 deficiency may also contribute to MS immunogenetic heterogeneity.
Area of Science:
- Immunogenetics
- Human Genetics
- Molecular Biology
Context:
- Investigated genetic factors in multiple sclerosis (MS) families.
- Part of the 11th International Histocompatibility Workshop Study (IHWS).
- Focused on Human Leukocyte Antigen (HLA) and complement polymorphisms (BF, C2, C4).
Purpose:
- Define the MS susceptibility gene.
- Investigate the role of complement factors in MS etiopathogenesis.
- Explore immunogenetic heterogeneity in MS.
Summary:
- HLA-DRw15 and -DWw6 showed a strong association with MS in a Caucasian population.
- Heterozygous C2 deficiency linked with a specific haplotype (A25 B18 DR2 BFS C4A4 C4B2) suggests complement factor involvement.
- Linkage of HLA with MS susceptibility gene observed in MS sister pairs, but not confirmed in the overall family study.
Impact:
- Highlights the significant role of HLA in MS susceptibility.
- Suggests complement system involvement in MS pathogenesis, contributing to heterogeneity.
- Provides insights into the complex genetic architecture of multiple sclerosis.